昭衍生物于2024年1月20日宣布，通过资产交易方式收购位于广州知识城的龙沙大分子CDMO工厂。该工厂建筑面积约2.5万平方米，配备先进的生产设施 ...

在全球生物医药行业经历深度调整的背景下，CXO（医药研发及生产外包）领域近期掀起并购热潮。据不完全统计，2024年至今全球范围内已发生超过20起重大并购交易，涉及金额突破150亿美元，标志着行业进入新一轮资源整合期。

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with a transaction set to propel the company into the CDMO market.

1月20日，昭衍生物官方公众号发布文章称，公司以资产交易的方式收购广州知识城龙沙大分子CDMO（合同定制研发生产机构）工厂（下称“广州工厂”）。昭衍生物认为这是其进一步完善国际化 ...

承接海外实验室服务和部分跨国药企定向扶持的CDMO代工厂。 2015年“722”临床数据核查事件后，国内医保快速扩容并全面支持创新药，国内创新药的 ...

2025年以来，多家医药公司公告了对新药开发（CXO）产业链企业的并购计划。2月13日，多位受访人士在接受《证券日报》记者采访时表示，眼下CXO产业已经出现回暖迹象，企业抓紧并购相关标的，既是为补链、强链，也是在为承接潜在订单积极布局。

Ami Organics (CMP: Rs 2,359; Market Cap: Rs 9,652 crore; Rating: Overweight) posted a strong set of numbers in Q3FY25 as well, thanks to the ramp-up in the CDMO (Contract Development and ...

Delray Beach, FL, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 ...

Although Lonza posted slightly lower sales than analysts had expected in 2024, the Swiss CDMO suggested in its year-end report that it's in a stronger position going into 2025 thanks to improved ...

Granules India Limited on Friday announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing in peptides. The company said that this acquisition ...